RainDance Technologies and CLC bio Collaborate to Develop Specialized Software Solutions for Targeted Resequencing LEXINGTON, Mass. & AARHUS, Denmark–RainDance Technologies and CLC bio today announced a partnership to develop specialized software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution and next generation DNA sequencing platforms. “The rapid and […]
CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the “Existing Investors”) and Ron […]
Complete Genomics Demonstrates Its Technology’s Potential by Sequencing 14 Human Genomes for Customers – Its High-Quality, Low-Cost Human Genome Sequencing Technology is Helping to Further Cancer, Metabolic and Neurologic Disease Research MOUNTAIN VIEW, Calif.–Complete Genomics Inc., a third-generation human genome sequencing company, announced today that it has sequenced, analyzed and delivered 14 human genomes to […]
Single Molecule Sequencing Technology Will Play Integral Role in Japan’s National Sequencing Center CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ:HLCS) today announced that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos™ Genetic Analysis Systems. The transaction represents the first multisystem sale of the Helicos system to a large genome center. Shipments […]
Achieves Significant Commercial and Technical Milestones – Engages Thomas Weisel Partners to Advise on Strategic Alternatives CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS) announced today its operating highlights for the quarter ended June 30, 2009 and other recent developments following the filing of its Quarterly Report on Form 10-Q for the period ended June 30, 2009. […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) today announced that it has delivered Hermann Hauser’s genome sequence. Dr. Hauser, Partner, Amadeus Capital Partners Ltd, is the first consumer to purchase Illumina’s individual genome sequencing service working with his physician, Michael Nova, MD, of Pathway Genomics. The genome was completed in Illumina’s CLIA-certified and College of American Pathologists (CAP) […]
New Zealand-based scientific software company Biomatters Ltd, creators of Geneious Pro, and GenomeQuest, the leader in sequence data management (SDM), announce an alliance to offer researchers a landmark “top-down” discovery methodology for next generation sequencing (NGS) projects. Specifically, the companies will integrate Biomatters’ desktop analysis and visualization software, Geneious Pro™ v4.8, with GenomeQuest 6.0Beta, an […]
GATC Biotech is the first sequencing service provider in Germany with Illumina CSProTM certification Constance, Germany, August 27, 2009 – GATC Biotech is the first sequencing service provider in Germany to successfully complete the CSProTM certification process carried out by Illumina Inc. The CSProTM certificate (Certified Service Provider Program) is awarded to service providers all […]
Appoints Two New Directors – Proceeds will be used to expand the company’s commercial genome center in preparation for large-scale sequencing projects MOUNTAIN VIEW, Calif.–Complete Genomics Inc., a third-generation human genome sequencing company, announced that it has raised $45 million in private equity financing and closed its Series D funding round with two new investors […]
Leaders in the field of cancer genomics to leverage benefits of single molecule sequencing technology CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the placement of a Helicos™ Genetic Analysis System at the Ontario Institute for Cancer Research (OICR) with Drs. Tom Hudson and John […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
